A significant breakthrough in cancer research is arising with the use of VHH fragments to re-engage dysfunctional p53. This vital malignant inhibitor protein is frequently lost in several forms of cancer, causing https://peakbookmarks.com/story22029196/nanobodies-reactivate-tumor-suppressor-p53-a-new-pathway-for-malignant-treatment